F. Hoffmann-La Roche Ltd. v. Empagran S.A.
Citation and Court
542 U.S. 155 (2004), Supreme Court of the United States
Facts
Several foreign purchasers of vitamins brought suit under the Sherman Act against vitamin manufacturers, alleging participation in a global price-fixing cartel. The domestic effects of the cartel were significant. The foreign plaintiffs’ injuries, however, arose solely from price-fixing in the foreign markets where they purchased vitamins — injuries that were independent of any domestic effect. The question was whether the Foreign Trade Antitrust Improvements Act (FTAIA) permitted such claims.
Issue
Whether the Sherman Act, as limited by the FTAIA, permits foreign plaintiffs to sue for antitrust injuries that arise from foreign conduct whose harmful effects on foreign commerce are independent of any effect on U.S. domestic commerce.
Holding
The FTAIA bars Sherman Act claims by foreign plaintiffs when their injuries arise from the foreign anticompetitive conduct’s independent effect on foreign markets, even if the same overall cartel had substantial domestic effects on U.S. commerce.
Rule / Doctrine
The FTAIA generally excludes from Sherman Act coverage conduct involving foreign commerce unless that conduct has a direct, substantial, and reasonably foreseeable effect on U.S. domestic commerce and that domestic effect gives rise to the plaintiff’s claim. When a foreign plaintiff’s injury flows from an independent foreign effect — one that is not causally linked to the domestic effect — the Sherman Act does not reach the claim. Principles of international comity reinforce this limitation on extraterritorial application.
Significance
Empagran is the leading case on the extraterritorial reach of U.S. antitrust law and the meaning of the FTAIA. It limits foreign plaintiffs from piggybacking on U.S. domestic antitrust enforcement to recover for purely foreign injuries, invoking comity to avoid conflicts with foreign nations’ rights to regulate their own markets. The case is central to courses on transnational litigation and international antitrust.